United Kingdom to Start Testing of Type 1 Vaccine in Humans


By: Daniel Trecroci

A vaccine for type 1s will be tested on 18 human volunteers with type 1 this summer in the United Kingdom. Researchers at the University of Bristol in southwest England and King’s College in London say that the vaccine could be on the market in 10 years’ time.

The vaccine, developed by CLinalfa, a part of the Merck pharmaceutical group, has a molecule that is identical to part of the islets. When this molecule is added to human blood, it stops white blood cells from destroying pancreatic insulin-producing islets.

Trials with the vaccine have been successful in mice.

* * *

Sources: Medical News Today, Agence France Presse, Diabetes U.K.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.